| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.08 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.083 | 0.09 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |